300 related articles for article (PubMed ID: 23015379)
41. Recurrence of cryptococcal meningitis in HIV-infected patients following immune reconstitution.
Seddon J; Mangeya N; Miller RF; Corbett EL; Ferrand RA
Int J STD AIDS; 2009 Apr; 20(4):274-5. PubMed ID: 19304977
[TBL] [Abstract][Full Text] [Related]
42. Cryptococcal antigenemia in anti-retroviral naïve AIDS patients: prevalence and its association with CD4 cell count.
Osazuwa OF; Dirisu O; Okuonghae E
Acta Med Iran; 2012; 50(5):344-7. PubMed ID: 22837089
[TBL] [Abstract][Full Text] [Related]
43. Prevalence of cryptococcal infection among advanced HIV patients in Argentina using lateral flow immunoassay.
Frola C; Guelfand L; Blugerman G; Szyld E; Kaufman S; Cahn P; Sued O; Pérez H
PLoS One; 2017; 12(6):e0178721. PubMed ID: 28617817
[TBL] [Abstract][Full Text] [Related]
44. The role of cryptococcal antigen assay in diagnosis and monitoring of cryptococcal meningitis.
Antinori S; Radice A; Galimberti L; Magni C; Fasan M; Parravicini C
J Clin Microbiol; 2005 Nov; 43(11):5828-9. PubMed ID: 16272534
[No Abstract] [Full Text] [Related]
45. Symptomatic Cryptococcal Antigenemia Presenting as Early Cryptococcal Meningitis With Negative Cerebral Spinal Fluid Analysis.
Ssebambulidde K; Bangdiwala AS; Kwizera R; Kandole TK; Tugume L; Kiggundu R; Mpoza E; Nuwagira E; Williams DA; Lofgren SM; Abassi M; Musubire AK; Cresswell FV; Rhein J; Muzoora C; Hullsiek KH; Boulware DR; Meya DB;
Clin Infect Dis; 2019 May; 68(12):2094-2098. PubMed ID: 30256903
[TBL] [Abstract][Full Text] [Related]
46. A comparative evaluation of three methods for the rapid diagnosis of cryptococcal meningitis (CM) among HIV-infected patients in Northern Malawi.
Chisale MR; Salema D; Sinyiza F; Mkwaila J; Kamudumuli P; Lee HY
Malawi Med J; 2020 Mar; 32(1):3-7. PubMed ID: 32733652
[TBL] [Abstract][Full Text] [Related]
47. Prevalence, determinants of positivity, and clinical utility of cryptococcal antigenemia in Cambodian HIV-infected patients.
Micol R; Lortholary O; Sar B; Laureillard D; Ngeth C; Dousset JP; Chanroeun H; Ferradini L; Guerin PJ; Dromer F; Fontanet A
J Acquir Immune Defic Syndr; 2007 Aug; 45(5):555-9. PubMed ID: 17577124
[TBL] [Abstract][Full Text] [Related]
48. Adjunctive sertraline for asymptomatic cryptococcal antigenemia: A randomized clinical trial.
Boulware DR; Nalintya E; Rajasingham R; Kirumira P; Naluyima R; Turya F; Namanda S; Rutakingirwa MK; Skipper CP; Nikweri Y; Hullsiek KH; Bangdiwala AS; Meya DB
Med Mycol; 2020 Nov; 58(8):1037-1043. PubMed ID: 32415846
[TBL] [Abstract][Full Text] [Related]
49. CD4 Cell Count Threshold for Cryptococcal Antigen Screening of HIV-Infected Individuals: A Systematic Review and Meta-analysis.
Ford N; Shubber Z; Jarvis JN; Chiller T; Greene G; Migone C; Vitoria M; Doherty M; Meintjes G
Clin Infect Dis; 2018 Mar; 66(suppl_2):S152-S159. PubMed ID: 29514236
[TBL] [Abstract][Full Text] [Related]
50. Screening for cryptococcal antigenemia in patients accessing an antiretroviral treatment program in South Africa.
Jarvis JN; Lawn SD; Vogt M; Bangani N; Wood R; Harrison TS
Clin Infect Dis; 2009 Apr; 48(7):856-62. PubMed ID: 19222372
[TBL] [Abstract][Full Text] [Related]
51. Prevalence, correlates, and outcomes of cryptococcal antigen positivity among patients with AIDS, United States, 1986-2012.
McKenney J; Bauman S; Neary B; Detels R; French A; Margolick J; Doherty B; Klausner JD
Clin Infect Dis; 2015 Mar; 60(6):959-65. PubMed ID: 25422390
[TBL] [Abstract][Full Text] [Related]
52. Benefits of enhanced infection prophylaxis at antiretroviral therapy initiation by cryptococcal antigen status.
Pett SL; Spyer M; Haddow LJ; Nhema R; Benjamin LA; Najjuka G; Bilima S; Daud I; Musoro G; Kitabalwa J; Selemani G; Kandie S; Cornelius KM; Katemba C; Berkley JA; Hassan AS; Kityo C; Hakim J; Heyderman RS; Gibb DM; Walker AS;
AIDS; 2021 Mar; 35(4):585-594. PubMed ID: 33306556
[TBL] [Abstract][Full Text] [Related]
53. The cost-effectiveness of prophylaxis strategies for individuals with advanced HIV starting treatment in Africa.
Walker SM; Cox E; Revill P; Musiime V; Bwakura-Dangarembizi M; Mallewa J; Cheruiyot P; Maitland K; Ford N; Gibb DM; Walker AS; Soares M;
J Int AIDS Soc; 2020 Mar; 23(3):e25469. PubMed ID: 32219991
[TBL] [Abstract][Full Text] [Related]
54. Laboratory-Reflex Cryptococcal Antigen Screening Is Associated With a Survival Benefit in Tanzania.
Faini D; Kalinjuma AV; Katende A; Mbwaji G; Mnzava D; Nyuri A; Glass TR; Furrer H; Hatz C; Boulware DR; Letang E
J Acquir Immune Defic Syndr; 2019 Feb; 80(2):205-213. PubMed ID: 30422904
[TBL] [Abstract][Full Text] [Related]
55. Cryptococcal Antigenemia in Advanced Human Immunodeficiency Virus Disease: Pathophysiology, Epidemiology, and Clinical Implications.
Wake RM; Molloy SF; Jarvis JN; Harrison TS; Govender NP
Clin Infect Dis; 2023 Feb; 76(4):764-770. PubMed ID: 35986670
[TBL] [Abstract][Full Text] [Related]
56. Clinical utility of monitoring serum cryptococcal antigen (sCRAG) titers in patients with AIDS-related cryptococcal disease.
Aberg JA; Watson J; Segal M; Chang LW
HIV Clin Trials; 2000; 1(1):1-6. PubMed ID: 11590483
[TBL] [Abstract][Full Text] [Related]
57. Screening HIV-Infected Patients with Low CD4 Counts for Cryptococcal Antigenemia prior to Initiation of Antiretroviral Therapy: Cost Effectiveness of Alternative Screening Strategies in South Africa.
Larson BA; Rockers PC; Bonawitz R; Sriruttan C; Glencross DK; Cassim N; Coetzee LM; Greene GS; Chiller TM; Vallabhaneni S; Long L; van Rensburg C; Govender NP
PLoS One; 2016; 11(7):e0158986. PubMed ID: 27390864
[TBL] [Abstract][Full Text] [Related]
58. Impact of prior cryptococcal antigen screening on in-hospital mortality in cryptococcal meningitis or fungaemia among HIV-seropositive individuals in South Africa: a cross-sectional observational study.
Paccoud O; Shuping L; Mashau R; Greene G; Quan V; Meiring S; Govender NP;
Clin Microbiol Infect; 2023 Aug; 29(8):1063-1069. PubMed ID: 37086780
[TBL] [Abstract][Full Text] [Related]
59. Burden of cryptococcal meningitis in Malawi.
Makombe SD; Nkhata A; Schouten EJ; Kamoto K; Harries AD
Trop Doct; 2009 Jan; 39(1):32-4. PubMed ID: 19211421
[TBL] [Abstract][Full Text] [Related]
60. High prevalence of Cryptococcal antigenemia among HIV-infected patients receiving antiretroviral therapy in Ethiopia.
Alemu AS; Kempker RR; Tenna A; Smitson C; Berhe N; Fekade D; Blumberg HM; Aseffa A
PLoS One; 2013; 8(3):e58377. PubMed ID: 23469276
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
